Dr Shanthini Crusz & Dr Marco Gerlinger

Dr Shanthini Crusz is a Clinical Research Fellow at Barts Cancer Institute in London where she studies clinical implications of intratumour heterogeneity and contribution of immune cells to metastatic pancreatic cancer progression.

Dr Marco Gerlinger is a Clinician Scientist in the Centre for Evolution and Cancer at the Institute of Cancer Research, London and a Consultant Medical Oncologist at the Royal Marsden Hospital in London. His work focuses on understanding and controlling cancer evolution in solid tumours through adaptive therapy approaches, drug resistance reversal and combination immunotherapies.

Latest posts by Dr Shanthini Crusz & Dr Marco Gerlinger (see all)